Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2070]
News [6432]
Articles [133]
Editorials [5]
Conferences [170]
elearning [10]
Anti-Bcl2 therapy shows promise for relapsed/refractory multiple myeloma
Dr Shaji Kumar - Mayo Clinic, Rochester, USA
Anti-Bcl2 therapy shows promise for relapsed/refractory multiple myeloma ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )
5 Dec 2015
Comment: Classification system based on cytogenetics and treatment response...
Dr Wendy Stock - University of Chicago, Chicago, USA
Comment: Classification system based on cytogenetics and treatment response identifies leukaemia patients with high-risk clinical features ( Dr Wendy Stock - University of Chicago, Chicago, USA )
5 Dec 2015
Comment: Study identifies genetic variant that signifies higher risk for...
Dr Wendy Stock - University of Chicago, Chicago, USA
Comment: Study identifies genetic variant that signifies higher risk for avascular necrosis in children with acute leukaemia ( Dr Wendy Stock - University of Chicago, Chicago, USA )
5 Dec 2015
Engineered cells to target multiple myeloma
Dr James Kochenderfer - National Cancer Institute, Bethesda, USA
Engineered cells to target multiple myeloma ( Dr James Kochenderfer - National Cancer Institute, Bethesda, USA )
5 Dec 2015
Classification system based on cytogenetics and treatment response identifies...
Dr Elizabeth Raetz - University of Utah, Salt Lake City, USA
Classification system based on cytogenetics and treatment response identifies leukaemia patients with high risk clinical features with outstanding outcomes ( Dr Elizabeth Raetz - University of Utah, Salt Lake City, USA )
5 Dec 2015
Study identifies genetic variant that signifies higher risk for avascular...
Dr Peter D. Cole - Albert Einstein College of Medicine, New York, USA
Study identifies genetic variant that signifies higher risk for avascular necrosis in children with acute leukaemia ( Dr Peter D. Cole - Albert Einstein College of Medicine, New York, USA )
5 Dec 2015
Making the prevention of cancer a routine part of mainstream healthcare
Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, United...
Making the prevention of cancer a routine part of mainstream healthcare ( Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, United Kingdom )
4 Dec 2015
The knock-on effects of breast cancer drugs
Prof V Craig Jordan - University of Texas MD Anderson Cancer Center, Houston...
The knock-on effects of breast cancer drugs ( Prof V Craig Jordan - University of Texas MD Anderson Cancer Center, Houston, USA )
4 Dec 2015
Biobanking in the EurocanPlatform project
Dr Peter Riegman - Erasmus University Medical Centre, Rotterdam, The Netherlands
Biobanking in the EurocanPlatform project ( Dr Peter Riegman - Erasmus University Medical Centre, Rotterdam, The Netherlands )
4 Dec 2015
Therapeutic strategies in the EurocanPlatform project
Prof Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona...
Therapeutic strategies in the EurocanPlatform project ( Prof Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
4 Dec 2015
Cancer Core Europe: what has been achieved one year on?
Prof Alexander Eggermont and Prof Julio Celis
Cancer Core Europe: what has been achieved one year on? ( Prof Alexander Eggermont and Prof Julio Celis )
2 Dec 2015
Highlights of the EurocanPlatform Project
Highlights of the EurocanPlatform Project ( )
2 Dec 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation